Abstract:Analyzing treatment effectiveness from electronic health records (EHR) presents unique challenges in causal inference, particularly when comparing multiple treatment options with high-dimensional covariates. We propose a novel framework combining instrumental variable (IV) analysis with advanced Bayesian feature selection methods and neural networks to estimate causal effects in multi-valued treatment settings. Our approach addresses three key methodological challenges: handling multiple treatment comparisons simultaneously, comparing Bayesian fea- ture selection methods, and selecting relevant features while capturing complex nonlinear relationships in outcome models. Through extensive simulation studies, we demonstrate that spike-and-slab priors achieve superior performance in treatment effect estimation with the lowest mean absolute bias (0.071) compared to ALL (0.074), LASSO (0.080), and Bayesian LASSO (0.083) methods. The consistency of bias control across treatment pairs demonstrates the robustness of our Bayesian feature selection approach, particularly in identifying clinically relevant predictors. We apply this framework to compare three commonly used vasopressors (norepinephrine, vasopressin, and phenylephrine) using MIMIC-IV data[1]. Using physician prescribing preferences as instruments[2, 3, 4], our anal- ysis reveals a clear hierarchical pattern in treatment effectiveness. Vasopressin demonstrated superior effectiveness compared to both norepinephrine (ATE = 0.134, 95% CI [0.115, 0.152]) and phenylephrine (ATE = 0.173, 95% CI [0.156, 0.191]), while phenylephrine showed inferior outcomes compared to norepinephrine (ATE = -0.040, 95% CI [-0.048, -0.031]). Our methodological framework provides a robust approach for analyzing multi-valued treatments in high-dimensional observational data, with broad applications beyond vessopressors in critical care. The integration of instrumental variable analysis, Bayesian feature selection, and advanced modeling techniques offers a promising direction for using EHR data to inform treatment decisions while addressing key challenges in causal inference.

Bayesian model selection on linear mixed-effects models for comparisons between multiple treatments and a control

A Bayesian Alternative to Synthetic Control for Comparative Case Studies

BASIC: A Bayesian Adaptive Synthetic-Control Design for Phase II Clinical Trials.

A Bayesian Platform Trial Design to Simultaneously Evaluate Multiple Drugs in Multiple Indications with Mixed Endpoints.

Bayesian Variable Selection for Probit Mixed Models Applied to Gene Selection

A unified Bayesian framework for bias adjustment in multiple comparisons from clinical trials

Bayesian estimation for longitudinal data in a joint model with HPCs

Bayesian Index Models for Heterogeneous Treatment Effects on a Binary Outcome

Bayesian model selection in complex linear systems, as illustrated in genetic association studies

A Bayesian platform trial design with hybrid control based on multisource exchangeability modelling

Compatibility of Prior Specifications Across Linear Models

Bayesian Variable Selection for Mixed Effects Model with Shrinkage Prior.

Bayesian Multivariate Logistic Regression for Superiority and Inferiority Decision-Making under Observable Treatment Heterogeneity

Bayesian joint analysis of heterogeneous- and skewed-longitudinal data and a binary outcome, with application to AIDS clinical studies

Study of Bayesian variable selection method on mixed linear regression models

A comparison of methods for model selection when estimating individual treatment effects

Bayesian sample sizes for exploratory clinical trials comparing multiple experimental treatments with a control

Bias correction for multiple covariate analysis using empirical bayesian estimation in mixed-effects models for longitudinal data

Bayesian analysis for pretest-posttest binary outcomes with adaptive significance levels

Bayesian Feature Selection for Multi-valued Treatment Comparisons: An Electronic Health Records Study of Vasopressor Effectiveness

Bayesian analysis of longitudinal studies with treatment by indication